Selective Serotonin Reuptake Inhibitors for Treatment of Selective Mutism

Year 2012, Volume: 2012 Issue: 1, 99 - 102, 01.01.2012

Mazlum Çöpür İşık Görker Türkay Demir

https://doi.org/10.5174/tutfd.2010.04056.1

Abstract

Some authors suggest that selective mutism should be considered as a variant of social phobia or a disorder in the obsessive-compulsive spectrum. Recent studies indicate that pharmacological treatments may be effective in the treatment of selective mutism. In this article, four cases who were treated with citalopram and escitalopram are presented. The results indicate that the drugs were well tolerated, and the level of social and verbal interactions improved significantly. These findings have shown that citalopram and escitalopram can be considered in medication of selective mutism; nevertheless, it is essential that research be done with more cases than previous ones, in order to prove their accuracy Turkish Başlık: Selektif Mutismin Tedavisinde SSRI' ların Kullanımı Anahtar Kelimeler: Selektif mutism, çocuklar, essitalopram, sitalopram Bazı yazarlar selektif mutismin, sosyal fobinin bir varyantı olduğunu veya obsesif kompulsif bozukluk spektrumu içinde yer aldığını ileri sürmektedirler.Son yapılan çalışmalar selektif mutismin tedavisinde ilaçların etkili olabileceğini göstermektedir.Bu makalede sitalopram ve essitalopram ile tedavi edilen dört elektif mutism olgusu sunulmaktadır. Sonuçlar, bu iki ilacın olgularca iyi tolere edildiğini, verbal ve sosyal etkileşimin geliştiğini göstermiştir. Bu veriler sitalopram ve essitalopramın, selektif mutismin farmakolojik tedavisinde dikkate alınabileceğini düşündürmekle birlikte, daha net bilgiler elde etmek için geniş hasta gruplarında yeni çalışmaların yapılması gerekir..

Keywords

Selective mutism, children, escitalopram, citalopram

Selective Serotonin Reuptake Inhibitors for Treatment of Selective Mutism

Abstract

References

• Kussmaul A. Die Störungen der Sprache. Leipzig, FCV Vogel; 1877.
• Tramer M. Elective mutism. Z. Kinderpsychiatr 1934;1:30-5.
• World HealthOrganization. ICD- 10 international classification of mental disorders. Geneva: World Health Organization; 1992.
• Brown JB, Lloyd H. A controlled study of children not speaking at school. J Assoc Workers Maladjust Child 1975;49-63.
• Browne E, Wilson V, Layborn PC. Diagnosis and treatment of elec- tive mutism in children.J Am Acad Child Psychiatry1963;2:605-17. [CrossRef]
• Glowny DH, Weinstock RC. Phenelyzine treatment of elective mutism.Journal of Clinical Psychiatry 1990;51:384-5.
• Dow SP, Sonies BC, Scheib D, Moss SE, Leonard HL. Practical guidelines for the assessment and treatment of selective mutism. J Am Acad Child Adolesc Psychiatry 1995;34:836-46. [CrossRef]
• Wright HH, Holmes GR, Cuccaro ML, Leonhardt TV. A guided bibliography of selective mutism (elective mutism) literature. Psy- chol Rep 1994;74:995-1007. [CrossRef]
• Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry1992;31:1090-4. [CrossRef]
• Black B, Uhde TW. Fluoxetine treatment of elective mutism; a double blind plecebo controlled study. J Am Acad Child Adolesc Psychiatry 1994;33:1000-6. [CrossRef]
• Dummit ES, Klein RG, Tancer NK, Asche BK, Martın J. Fluoxetine treatment of children with selective mutism: an open trial.J Am Acad Child Adolesc Psychiatry 1996;35:615-21. [CrossRef]
• Lepola U, Leisonen E, Koponen H. Letter to the editor- Citalo- pram in anxiety disorder of childhood and adolescence.Eur Child and Adolesc Psychiatry 1994;3:277-9. [CrossRef]
• Sourander A. Case study: Selective serotonin reuptake inhibitors in the treatment of severely disturbed preadolescents with co- morbid diagnosis. Nord J Psychiatry 1999;3:431-3. [CrossRef]
• Lepola U, Leinonen E, Koponen H. Citalopram in the treatment of early onset panic disorder an school phobia. Pharmacopsy- chiat 1996;29:30-2. [CrossRef]
• Thomson PH., Rasmussen G., Anderson CB.:Elective mutism: A 17-year old girl treated success fully with citalopram.Nord J Psy- chiatry 1999;53:427-9. [CrossRef]
• Davidson JR, Bose A, Korotzer A, Zheng H. Escitalporam in the treatment of generalized anxiety disorder:Double- blind, plecabo controlled flexible dose study.Depression and Anxiety.Publıshed online 2004;19:234-40.
• Bernstein GA, Layne AE. Introduction: Social Phobia. In: Sadock BJ,editor. Comprehensive Textbook of Psychiatry. New York: Lip- incott Wiliam& Wilkins; 2005.
• American Psychiatric Association: Diagnostic and Statistical Man- ual of Mental Disorders, Fourth Edition. Washington: DC, Ameri- can Psychiatric Association; 1994.
• Dow SP, Sonies BC, Scheib D, Moss SE, Leonard HL. Practical guidelines fort theAssessment and treatment of selective mutism. J Am Acad Child Adolesc Psychiatry 1995;34:836-46. [CrossRef]